Research
-
Examination of the TrkB receptor signalling pathway throughout the retina of glaucoma patients versus age-matched controls.
This project will improve our understanding of BDNF signalling in human retinal tissue.
CompletedApril 2018 - December 2019 -
Genetics of Advanced Glaucoma: Towards Predicting and Preventing Blindness
Identifying the best treatment option for patients who present with advanced glaucoma.
ActiveJanuary 2018 - March 2024 -
Targeting NAD+ for retinal ganglion cell protection in experimental glaucoma
CompletedOctober 2019 - December 2022 -
Understanding the genetic basis for steroid-induced eye pressure to develop personalised medicine
The aim is to develop a genetic test that will predict how a patient will respond to steroids, which are widely used to treat a range of eye conditions.
ActiveApril 2020 - March 2025 -
Promoting RGC survival and optic nerve regeneration by enhancing the axon transport of growth and survival receptors
Regeneration of the optic nerves may be able to restore vision to those blinded by optic nerve disease and eventually make eye transplants possible.
CompletedJanuary 2019 - September 2022 -
Lifestyle determinants of intra-ocular pressure and glaucoma
Investigating the effect of a variety of lifestyle factors on eye pressure and the subsequent development of primary open angle glaucoma.
ActiveJuly 2021 - June 2024 -
Investigating how brain-derived neurotrophic factor (BDNF) could prevent cell death in glaucoma
CompletedDecember 2020 - December 2021 -
miRNA-mediated therapy for the treatment of glaucoma
Investigating the role of micro RNA - thought to be an integral part of the disease mechanism in glaucoma - and explore its therapeutic potential for the condition through pre-clinical testing.
ActiveAugust 2022 - July 2025 -
Identifying measurements to predict childhood secondary glaucoma risk
ARGO-1: Study of Anterior segment imaging based Risk stratification of childhood secondary Glaucoma.
ActiveFebruary 2023 - November 2024